Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Innovotech ( (TSE:IOT) ) just unveiled an announcement.
Innovotech Inc. announced that it will present at the 3rd Annual DealFlow Discovery Conference in Atlantic City on January 28–29, 2026, where CEO Craig Milne will deliver a company presentation and participate in one-on-one meetings with investors. The company’s participation in this conference is aimed at increasing visibility among the investment community and facilitating direct engagement with potential and existing shareholders, potentially supporting its growth plans and reinforcing its positioning as a specialized provider of advanced antimicrobial and laboratory services in regulated markets.
More about Innovotech
Innovotech Inc. is a Canadian boutique contract research organization specializing in advanced laboratory services and the commercialization of proprietary technologies for regulated industries. A leader in biofilm science, the company focuses on antimicrobial testing, pharmaceutical analysis and industrial laboratory solutions, supported by innovative tools such as its widely used MBEC Assay® kit for high-throughput antimicrobial and antibiotic testing. Innovotech serves clients across multiple sectors through ISO-certified and GMP-accredited laboratories that meet stringent regulatory standards set by authorities including the U.S. Food and Drug Administration and Health Canada.
Average Trading Volume: 31,481
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$13.61M
Learn more about IOT stock on TipRanks’ Stock Analysis page.